Loading news...
Angitia Biopharmaceuticals Series D
Angitia Biopharmaceuticals Series D
| Investor |
|---|
| Firm Type |
|---|
| Partner |
|---|
| Venture Capital | — | |
VenrockLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private Equity | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$336M
Top Valuation
-
Angitia Biopharmaceuticals raised $130M in a Series D round.
The round was announced on 02/05/26.
The round was led by Frazier Life Sciences, Venrock.